"Por meio do convênio nº 334/97, celebrado entre o Estado do Rio Grande do Sul e a Fundação Universidade de Caxias do Sul (FUCS), o Hospital Geral iniciou as suas atividades no dia 19 de março de 1998. Desde então, o HG assumiu o compromisso com a vida de mais de um milhão de habitantes. Passou a ser referência no atendimento a usuários do Sistema Único de Saúde (SUS) para 49 municípios da 5ª Coordenadoria Regional de Saúde."

During the past decade, Hospital Geral de Caxias do Sul conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Geral de Caxias do Sul" #1 collaborator was "Brazilian Research In Intensive Care Network" with 2 trials as a collaborator, "EMS" with 2 trials as a collaborator, "Hospital Israelita Albert Einstein" with 2 trials as a collaborator, "Hospital Sirio-Libanes" with 2 trials as a collaborator and "A Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Geral de Caxias do Sul" are "Coronavirus Infections" (2 trials), "Catheter-Associated Urinary Tract Infection" (1 trials), "Central Line-associated Bloodstream Infection (CLABSI)" (1 trials), "Health Care Associated Infection" (1 trials) and "Hyperhidrosis Primary Focal Palms" (1 trials). Many other conditions were trialed in "Hospital Geral de Caxias do Sul" in a lesser frequency.

Most popular intervention types in "Hospital Geral de Caxias do Sul" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Hydroxychloroquine + azithromycin" (2 trials), "2% chlorhexidine digluconate solution with surface-active agents" (1 trials), "Bilateral sequential sympathectomy" (1 trials), "Contralateral sympathectomy" (1 trials) and "Hydroxychloroquine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Geral de Caxias do Sul" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Geral de Caxias do Sul". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Geral de Caxias do Sul, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Geral de Caxias do Sul, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".